What drove ELV's strong Q3 2024 earnings performance?

Elevance Health, Inc. (ELV) delivered a robust financial performance in Q3 2024, driven by several key factors: 1. **Revenue Growth**: ELV's total revenue for the quarter was $45.11 billion. This represents a significant increase from the previous year, primarily attributed to higher premiums and improved investment income. 2. **Strategic Acquisitions**: The company's recent acquisitions have bolstered its market reach and diversified its service offerings, contributing to its revenue growth and enhanced competitiveness in the health insurance sector. 3. **Investment in Technology and Services**: ELV's continued investment in technology and services has reinforced its competitive advantage in the market, enabling it to provide better services and attract a larger customer base. 4. **Market Conditions**: Favorable market conditions, including rate cuts and favorable economic indicators, have contributed to improved investment income and overall financial performance. In summary, ELV's strong Q3 2024 earnings performance can be attributed to robust revenue growth, strategic acquisitions, investment in technology and services, and favorable market conditions.